David R. Epstein - May 31, 2022 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
Director
Signature
/s/ Daniel S. Char, Attorney-in-Fact for David R. Epstein
Stock symbol
EVLO
Transactions as of
May 31, 2022
Transactions value $
$0
Form type
4
Date filed
6/1/2022, 04:12 PM
Previous filing
May 31, 2022
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVLO Common Stock Options Exercise $0 +2.05K +2.44% $0.00 86.1K May 31, 2022 Direct F1
transaction EVLO Common Stock Options Exercise $0 +2.87K +3.34% $0.00 89K May 31, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Restricted Stock Units Options Exercise $0 -2.05K -49.99% $0.00 2.05K May 31, 2022 Common Stock 2.05K $0.00 Direct F2
transaction EVLO Restricted Stock Units Options Exercise $0 -2.87K -49.99% $0.00 2.87K May 31, 2022 Common Stock 2.87K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Settlement of shares of Common Stock acquired upon the vesting of Restricted Stock Units previously granted to the reporting person.
F2 The Restricted Stock Units vest in 12 substantially equal monthly installments following the June 30, 2021 grant date, subject to the reporting person's continued service as chair of the board of directors of the issuer on such vesting dates.
F3 The Restricted Stock Units vest in 12 substantially equal monthly installments following the June 30, 2021 grant date, subject to the reporting person's continued service as a consultant to the issuer on such vesting dates.